Curcumin Combined with Thalidomide Reduces Expression of STAT3 and Bcl-xL, Leading to Apoptosis in Acute Myeloid Leukemia Cell Lines

Autor: Mohammadi Kian M, Salemi M, Bahadoran M, Haghi A, Dashti N, Mohammadi S, Rostami S, Chahardouli B, Babakhani D, Nikbakht M

Publikováno v: Drug Design, Development and Therapy, Vol Volume 14, Pp 185-194 (2020)

Mahnaz Mohammadi Kian, 1, 2 Mahdieh Salemi, 1, 2 Mohammad Bahadoran, 3 Atousa Haghi, 1, 4 Nasrin Dashti, 5 Saeed Mohammadi, 1, 2 Shahrbano Rostami, 1, 2 Bahram Chahardouli, 1, 2 Davood Babakhani, 1 Mohsen Nikbakht 1, 2 1Hematology Oncology and Stem C

Externí odkaz: https://doaj.org/article/a9f2d0037d9841ecab78867a24da80aa

Evaluation of Janus Kinase 2 Exon 12 Mutations in Patients With JAK2V617F-negative Polycythemia Vera.

Autor: Khosravi S; Hematology Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran., Chahardouli B; Hematology Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran., Ebrahimi P; Student Research Committee, Babol University of Medical Sciences, Babol, Iran., Babaei FN; Student Research Committee, Babol University of Medical Sciences, Babol, Iran., Alimoghadam K; Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran., Rostami S; Hematology Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Publikováno v: Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2024 Mar 22; Vol. 17 (2), pp. 154-158.

ARMS-PCR Versus AS-PCR to evaluate JAK2V617F mutation in patients with non-CML myeloproliferative neoplasms

Autor: Nadali F, Ferdowsi Sh, Karimzadeh P, Chahardouli B, Einollahi N, Mousavi A, Bahar B, Dargahi H, Toogeh GhR, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH

Publikováno v: Tehran University Medical Journal, Vol 68, Iss 4, Pp 207-212 (2010)

"n Normal 0 false false false EN-US X-NONE AR-SA MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99

Externí odkaz: https://doaj.org/article/da66eee4a80844aeb45a4d2edf391355

Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study.

Autor: Barkhordar M; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran., Chahardouli B; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran., Biglari A; Department of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran., Ahmadvand M; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran., Bahri T; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran., Alaeddini F; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran., Sharifi Aliabadi L; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran., Noorani SS; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran., Bagheri Amiri F; Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran., Biglari M; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran., Shemshadi MR; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran., Ghavamzadeh A; Cancer & Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran., Vaezi M; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Apr 19; Vol. 14, pp. 1169666. Date of Electronic Publication: 2023 Apr 19 (Print Publication: 2023).

Author Correction: Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model.

Autor: Kazemi-Sefat GE; Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran., Keramatipour M; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Vaezi M; Hematology, Oncology and Stem Cell Transplantation Research CenterShariati Hospital, Tehran University of Medical Sciences, Tehran, Iran., Razavi SM; Oncopathology Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Kavousi K; Laboratory of Complex Biological Systems and Bioinformatics (CBB), Department of Bioinformatics, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran., Talebi A; Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Rostami S; Hematology, Oncology and Stem Cell Transplantation Research CenterShariati Hospital, Tehran University of Medical Sciences, Tehran, Iran., Yaghmaie M; Hematology, Oncology and Stem Cell Transplantation Research CenterShariati Hospital, Tehran University of Medical Sciences, Tehran, Iran., Chahardouli B; Hematology, Oncology and Stem Cell Transplantation Research CenterShariati Hospital, Tehran University of Medical Sciences, Tehran, Iran., Talebi S; Department of Medical Genetics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. talebi.s@iums.ac.ir., Mousavizadeh K; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran. mousavizadeh.k@iums.ac.ir.; Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. mousavizadeh.k@iums.ac.ir.

Publikováno v: Scientific reports [Sci Rep] 2023 Jan 13; Vol. 13 (1), pp. 736. Date of Electronic Publication: 2023 Jan 13.